Paul Tudor Jones II's position in Charles River Laboratories International is currently worth $7.96 Million. That's 0.10% of their equity portfolio (248th largest holding). The first Charles River Laboratories International trade was made in Q2 2013. Since then Paul Tudor Jones II bought shares 26 more times and sold shares on 21 occasions. The investor's estimated purchase price is $10.8 Million, resulting in a loss of 27%.